Finance

Beta
Lists
2160:TYO
GNI Group Ltd
¥2,684.00
+2.25%
(+59.00) 1D
Jun 4, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2160...
Open
¥2,600
High
¥2,740
Low
¥2,600
Mkt. cap
149.84B
Avg. vol.
1.10M
Volume
988.60K
52-wk high
¥4,340
52-wk low
¥2,112
EPS
-¥105
Shares outstanding
13.51M
No. of employees
990
Open
¥2,600
High
¥2,740
Low
¥2,600
Mkt. cap
149.84B
Avg. vol.
1.10M
Volume
988.60K
52-wk high
¥4,340
52-wk low
¥2,112
EPS
-¥105
Shares outstanding
13.51M
No. of employees
990
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to 2160 in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for 2160 in the last 3 months.
Highest
Current ¥2,684.00
¥3,800.00 (+41.58%)
Average
¥3,799.18 (+41.55%)
Lowest
¥3,800.00 (+41.58%)
News stories
From sources across the web
About GNI Group Ltd
CEO-
Employees990
FoundedNov 20, 2001
Headquarters-
SectorBiotechnology
Websitegnipharma.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.93B
7.10B
7.48B
5.53B
Cost of goods sold
2.21B
1.56B
1.86B
1.50B
Cost of revenue
2.21B
1.56B
1.86B
1.50B
Research and development expenses
789.41M
849.47M
852.00M
1.05B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.17B
3.95B
7.04B
5.46B
Operating expense
5.12B
4.86B
7.62B
6.77B
Total operating expenses
7.34B
6.42B
9.49B
8.27B
Operating income
-406.69M
683.54M
-2.01B
-2.75B
Other non operating income
-999.00K
-2.00M
203.00M
-
EBT including unusual items
-596.54M
349.95M
-3.55B
-3.19B
EBT excluding unusual items
-596.54M
349.95M
-2.38B
-3.19B
Income tax expense
479.22M
82.20M
1.52B
189.00M
Effective tax rate
-80.33%
23.49%
-42.96%
-5.93%
Other operating expenses
165.44M
54.93M
-267.00M
262.00M
Net income
-384.67M
420.38M
-3.75B
-2.13B
Net profit margin
-5.55%
5.92%
-50.10%
-38.49%
Earnings per share
-
-
-
-
Interest and investment income
163.25M
73.70M
-
135.00M
Interest expense
-365.19M
-403.17M
-584.00M
-588.00M
Net interest expenses
-201.94M
-329.47M
-584.00M
-453.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-146.25M
971.65M
-1.70B
-2.44B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer